Ellen Feigal
Dr. Ellen Feigal is a highly accomplished professional with a diverse educational background and extensive experience in the fields of medicine, research, and academia.
She holds a Medical Doctorate (MD) from the University of California, Davis - School of Medicine, where she focused on Internal Medicine during her residency at Stanford University School of Medicine.
Dr. Feigal also earned a Bachelor's and Master's degree in Biology with a specialization in Molecular Biology/Biochemistry from UC Irvine. Additionally, she completed a fellowship in Hematology/Oncology at the University of California, San Francisco - School of Medicine.
Throughout her career, Dr. Feigal has held various high-level positions in renowned organizations. She has served as an Adjunct Professor at Arizona State University, College of Law, and as a Partner at NDA Partners LLC.
Her previous roles include Senior Vice President of Research and Development at the California Institute for Regenerative Medicine, Executive Medical Director at Amgen, and Chief Medical Officer at Insys Therapeutics.
Dr. Feigal has also contributed to academia by serving as the Director of the American Course on Drug Development and Regulatory Sciences at the University of California, San Francisco, and as an Adjunct Professor at various institutions including Arizona State University, University of Arizona, and the UC San Diego School of Medicine.
Her research and clinical experience extend to roles such as Director of Medical Devices at The Critical Path Institute, Deputy Scientific Director/Vice President of Clinical Sciences at the Translational Genomics Research Institute, and Senior Investigator at the National Cancer Institute's Cancer Therapy Evaluation Program.
Furthermore, Dr. Feigal has held teaching positions at the National Cancer Institute, University of California, San Diego School of Medicine, and University of California, San Francisco School of Medicine.
With her extensive background in medicine, research, academia, and leadership, Dr. Ellen Feigal continues to make significant contributions to the fields of healthcare and life sciences.
